Anthony Rossomando
Alnylam Pharmaceuticals (United States)(US)Synageva BioPharma (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Melanoma and MAPK Pathways, Viral Infectious Diseases and Gene Expression in Insects, Nerve injury and regeneration, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).(1991)1,043 cited
- → Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase.(1989)439 cited
- → Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase.(1990)242 cited
- → Multiple actions of systemic artemin in experimental neuropathy(2003)158 cited
- → A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts.(1990)142 cited
- → Autophosphorylation in vitro of recombinant 42-kilodalton mitogen-activated protein kinase on tyrosine.(1991)142 cited